PRIMACYT is extending its product range by turkey hepatocytes.



Schwerin, Germany January 15, 2018

Primacyt Cell Culture Technology GmbH announces the extension of its range of cryopreserved hepatocytes by turkey hepatocytes, available as from today.

Avian hepatocytes are an important model system for risk assessment of chemicals. In environmental toxicology, hepatocytes are used to analyze, evaluate and predict the bioaccumulation and toxicity of pesticides and herbicides in wildlife and farm animals. Primacyt now offers cryopreserved turkey hepatocytes to complement the already existing portfolio of duck and chicken hepatocytes.


GAM-1801-tnvxgP3BSOIG


PRIMACYT expands its Network for Hepatocytes


PRIMACYT expands its Network of Human Hepatocytes.
Schwerin, Germany December 12, 2017

PRIMACYT Cell Technologies GmbH reports enlarging its international network by Cytes Biotechnologies. Cytes Biotechnologies, S.L. is a biotechnology company designed to offer services based on cells isolation and cell solutions for in-vitro models addressed to the research community.

The Company is located in the Parc Científic de Barcelona, Spain. Their services comprise liver cell isolation coordination, providing scientific and technical services consisting of isolation, preservation and cellular cultivation coordination and distribution for biomedical research, including drug development, cell biology, and cell therapy.

From now on, Cytes cryopreserved human hepatocytes are available at PRIMACYT's storefront for worldwide delivery. The human hepatocytes can be used for induction studies and other use in suspension.

To visit PRIMACYT's portfolio of Cytes products,
follow this link.

PRIMACYT exhibits at the ISSX 2017 in Cologne/ Germany.

Join us at ISSX 2017 in Cologne

PRIMACYT is a sponsor of the 14th European ISSX Meeting
26. - 29. June I Gürzenich I Cologne Germany
Martinstr. 29 - 37, 50667 Cologne

Please find further information
here.

We invite you to visit our poster, entitled "Establishing a platform of uptake transporters in HEK-293 cells for the analysis of possible drug-drug interactions".

Anett Ulrich will present the technology platform and will be happy to answer your questions.

Take the opportunity to meet our scientific experts at booth No. 207, discuss the most suitable in-vitro systems for your research and development.


Best regards,
Your PRIMACYT Team
GSN-185755-I